Status:
COMPLETED
Does a Non-Opioid Multimodal Pain (NOMO) Protocol Decrease Narcotic Use
Lead Sponsor:
Prisma Health-Upstate
Conditions:
Opioid Use
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The objective of this study is to evaluate narcotic use after implementation of a Non-Opioid Multimodal Pain (NOMO) protocol in patients who are undergoing a urogynecologic procedure. The study will a...
Detailed Description
The objective of this study is to evaluate narcotic use after implementation of a Non-Opioid Multimodal Pain (NOMO) protocol in patients who are undergoing a urogynecologic procedure. NOMO protocols s...
Eligibility Criteria
Inclusion
- English-speaking females
- greater than or equal to 18 years old
- scheduled for a urogynecologic procedure at GHS requiring inpatient stay or extended observation.
Exclusion
- less than 18 years of age
- non-English speaking patients
- unscheduled urogynecologic surgeries
- patients expected to undergo a simple reconstructive surgery with same-day discharge,
- history of chronic pain
- chronic Lyrica or Celebrex use
- psychiatric disorder, narcotic dependence or narcotic prescription in the past six weeks
- current liver disease
- kidney disease (defined as GFR \<60)
- malignancy
- sulfa allergy
Key Trial Info
Start Date :
November 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05386069
Start Date
November 15 2019
End Date
June 1 2021
Last Update
May 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prisma Health - Upstate
Greenville, South Carolina, United States, 29615